Cytosorb® becomes a featured blood purification therapy on fresenius medical care critical care platforms

Fresenius medical care and cytosorbents have expanded their partnership via a multi-stage collaboration designed to seize new sales opportunities and jointly develop future innovations cytosorb will be featured on fresenius medical care's critical care platforms for the removal of cytokines, bilirubin, and myoglobin fresenius medical care will be responsible for the specific worldwide marketing and combined promotion of cytosorb with its critical care products utilizing multiple highly visible and prominent marketing channels and campaigns cytosorbents' proprietary hemoadsorption cytosorb therapy expands the dimensions of blood purification of the fresenius medical care critical care product portfolio bad homburg v.d. hÖhe, germany and princeton, n.j.
FMS Ratings Summary
FMS Quant Ranking